News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,940 Results
Type
Article (16889)
Company Profile (67)
Press Release (241984)
Section
Business (72589)
Career Advice (671)
Deals (11830)
Drug Delivery (33)
Drug Development (42607)
Employer Resources (40)
FDA (6988)
Job Trends (5888)
News (133897)
Policy (12559)
Tag
Academia (1545)
Alliances (16642)
Alzheimer's disease (849)
Approvals (6973)
Artificial intelligence (43)
Bankruptcy (120)
Best Places to Work (5133)
Biotechnology (51)
Breast cancer (62)
Cancer (540)
Cardiovascular disease (70)
Career advice (553)
Cell therapy (112)
Clinical research (33723)
Collaboration (165)
Compensation (74)
COVID-19 (1094)
Cystic fibrosis (42)
Data (715)
Diabetes (86)
Diagnostics (2545)
Earnings (30946)
Events (38155)
Executive appointments (134)
FDA (7270)
Funding (167)
Gene therapy (111)
GLP-1 (301)
Government (2022)
Healthcare (8219)
Infectious disease (1138)
Inflammatory bowel disease (44)
Interviews (90)
IPO (6107)
Job creations (953)
Job search strategy (510)
Layoffs (120)
Legal (2270)
Lung cancer (82)
Manufacturing (52)
Medical device (4876)
Medtech (4877)
Mergers & acquisitions (5774)
Metabolic disorders (230)
Neuroscience (996)
NextGen Class of 2024 (2486)
Non-profit (2063)
Northern California (807)
Obesity (116)
Opinion (69)
Parkinson's disease (40)
Patents (43)
People (21005)
Phase I (10016)
Phase II (15129)
Phase III (11325)
Pipeline (270)
Postmarket research (1422)
Preclinical (4768)
Radiopharmaceuticals (112)
Rare diseases (108)
Real estate (1396)
Regulatory (8894)
Research institute (1126)
Resumes & cover letters (108)
Southern California (675)
Startups (1363)
United States (6109)
Vaccines (206)
Weight loss (71)
Date
Today (63)
Last 7 days (276)
Last 30 days (1768)
Last 365 days (16622)
2024 (15330)
2023 (18411)
2022 (22584)
2021 (24473)
2020 (22656)
2019 (18854)
2018 (14177)
2017 (13263)
2016 (12276)
2015 (14845)
2014 (10356)
2013 (8038)
2012 (8834)
2011 (9061)
2010 (8029)
Location
Africa (250)
Arizona (45)
Asia (12618)
Australia (2551)
California (1705)
Canada (550)
China (113)
Colorado (59)
Connecticut (61)
Europe (31642)
Florida (188)
Georgia (50)
Illinois (141)
Indiana (88)
Kansas (60)
Maryland (221)
Massachusetts (1029)
Michigan (55)
Minnesota (82)
New Jersey (487)
New York (492)
North Carolina (333)
Northern California (807)
Ohio (65)
Pennsylvania (363)
South America (344)
Southern California (675)
Texas (215)
Utah (41)
Washington State (203)
258,940 Results for "oregon bioscience association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The State of Oregon Agriculture Fertilizer Registration Certificate
February 6, 2024
·
7 min read
Lone Star Bio
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Lantern Pharma Inc. announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications.
May 6, 2024
·
15 min read
Business
Skanska signs additional contract to expand hospital in Portland, Oregon, USA, for USD 200M, about SEK 2.1 billion
Skanska has signed an additional contract with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
December 22, 2023
·
1 min read
Press Releases
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
October 31, 2024
·
5 min read
Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB announces that Oregon Health & Science University in the USA has placed an order for the treatment planning system RayStation®*.
October 31, 2023
·
1 min read
Press Releases
Precision for Medicine and Agena Bioscience Announce Strategic Partnership and Breakthrough Findings at Association for Molecular Pathology 2024 Annual Meeting & Expo
November 20, 2024
·
4 min read
Business
Bioscience Association Manitoba Appoints Andrea Ladouceur as President
The Bioscience Association Manitoba (BAM) is pleased to announce the appointment of Andrea Ladouceur as its new President.
January 16, 2024
·
2 min read
News
Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 for Infections Associated With Cystic Fibrosis
October 17, 2024
·
4 min read
Pharm Country
Decriminalizing Drug Possession Not Linked to Higher Overdose Death Rates in Oregon or Washington
In recent months, several media outlets have investigated an Oregon law that decriminalized possession of small amounts of controlled substances, including heroin, cocaine and methamphetamine, for some persons.
September 27, 2023
·
4 min read
Biotech Beach
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
Skye Bioscience, Inc. today announced that it will present two posters at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held May 5-9, 2024, in Seattle, Washington.
April 30, 2024
·
3 min read
1 of 25,894
Next
